Press Release

India Drug Delivery Devices Market to Grow with a CAGR of 6.11% through 2030

Technological advancements in the medical device manufacturing and rapid growth of the biopharmaceutical industry are expected to drive the India Drug Delivery Devices Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “India Drug Delivery Devices Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the India Drug Delivery Devices Market stood at USD 12.70 Billion in 2024 and is anticipated to grow with a CAGR of 6.11% in the forecast period, 2026-2030.  Several factors are propelling the growth of the Drug Delivery Devices market in India. A significant driving force is the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, necessitating effective drug delivery systems. Aging population and the associated increase in age-related ailments also contribute to this trend.

Advancements in technology are leading to the development of innovative and more efficient drug delivery devices, further stimulating market growth. The expansion of healthcare infrastructure and increased healthcare spending in India provide a conducive environment for market development.

Technological advancements in the field of drug delivery have played a crucial role in driving market growth. The development of controlled release drugs and advancements in drug delivery methods have made treatment more effective and convenient for patients. These advancements have not only improved the overall patient experience but also increased treatment adherence, leading to better health outcomes. The demand for drug delivery devices has been positively influenced by the increasing adoption of innovative strategies by key market players. These players are actively focusing on developing devices with advanced features, such as digital capabilities and the next generation of injectable devices. For example, Berry Global Group, in August 2021, announced plans to construct a second manufacturing plant and a worldwide center of excellence for healthcare in Bangalore, India. This strategic initiative aims to strengthen Berry's position in the market for inhalation devices and injectable devices, further driving the growth of the drug delivery device market in India.

However, it is important to note that the growth of the drug delivery device market in India is not without challenges. The risk of infections and side effects associated with these devices poses a concern for both patients and healthcare providers. Stringent regulatory guidelines for the approval of drug delivery devices can also hinder market growth. It is crucial for manufacturers and regulatory authorities to collaborate and ensure the safety and efficacy of these devices to overcome these challenges. Despite these challenges, the market for drug delivery devices in India is poised for significant expansion, driven by the increasing healthcare needs of the population and advancements in technology. The potential to improve patient outcomes and enhance the overall healthcare landscape in India makes this an exciting and promising market for drug delivery device manufacturers and stakeholders.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Drug Delivery Devices Market

The India Drug Delivery Devices Market is segmented into devices, route of administration, application, end user,  regional distribution, and company.

Based on end user, hospitals emerge as the dominant player in the Indian Drug Delivery Devices Market. Hospitals serve as primary points of healthcare delivery, catering to a wide range of medical needs, from routine check-ups to complex surgical procedures. Due to their extensive patient base and comprehensive healthcare services, hospitals drive substantial demand for various drug delivery devices.

Within hospitals, drug delivery devices find diverse applications across departments such as surgery, critical care, oncology, and chronic disease management. For instance, infusion pumps are widely utilized in hospital settings for precise administration of medications and fluids during surgeries, intensive care, and chemotherapy sessions. Similarly, inhalers and nebulizers are essential for respiratory therapy in hospital wards treating patients with asthma, COPD, or other respiratory conditions. Hospitals often have dedicated pharmacies or drug dispensing units where patients can access medications and drug delivery devices prescribed by healthcare professionals. This integrated approach facilitates seamless procurement and utilization of drug delivery devices within the hospital ecosystem. While diagnostic centres and ambulatory surgery centres also contribute to the demand for drug delivery devices, their scope of usage is comparatively narrower, primarily focusing on specific diagnostic procedures or outpatient surgeries. Thus, hospitals remain the dominant force shaping the Indian Drug Delivery Devices Market, driven by their extensive healthcare infrastructure and diverse patient care requirements.



Based on region, the western region of India holds a dominant position in the country's Drug Delivery Devices Market because this region serves as a major hub for pharmaceutical manufacturing, research, and innovation, with prominent cities like Mumbai, Ahmedabad, and Pune hosting numerous pharmaceutical companies, research institutes, and academic institutions. The concentration of industry expertise and infrastructure in the Western region facilitates the development and production of advanced drug delivery devices, ranging from injectable systems to implantable devices.

The Western region boasts a robust healthcare ecosystem, with a high density of hospitals, clinics, and medical facilities. These healthcare institutions drive substantial demand for drug delivery devices to meet the diverse needs of patients across various therapeutic areas, including cardiology, oncology, and diabetes management. The Western region's strategic geographical location and well-developed transportation infrastructure enhance its connectivity and accessibility, enabling seamless distribution and supply chain management of drug delivery devices across the country.

 

Major companies operating in India Drug Delivery Devices Market are:

  • Pfizer Ltd.
  • Novartis India Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • India Medtronic Private Ltd.
  • Cardinal Health International India Pvt Ltd.
  • B. Braun Medical (India) Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • 3M India Ltd.
  • Cipla Ltd.
  • Bayer Zydus Pharma


Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The India drug delivery devices market is expected to witness significant growth during the forecast period. This growth can be attributed to the increasing demand for drug delivery devices and the rising awareness about health among the population. The market is also driven by the introduction of technological advancements and novel products in the field of drug delivery. These smart drug delivery devices are designed to effectively manage various diseases. The rapid development in the health sector has led to an increased demand for drug delivery devices in India. With the changing lifestyle and the rise in the number of fatal diseases, there is a growing need for efficient drug delivery systems. These devices play a crucial role in ensuring the accurate and timely administration of medications, thus improving patient outcomes. The India drug delivery devices market is poised for significant growth in the coming years. The advancements in technology and the focus on improving healthcare outcomes are driving the demand for innovative drug delivery devices in the country.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

India Drug Delivery Devices Market By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others), By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Drug Delivery Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Drug Delivery Devices Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News